Editas Medicine (EDIT) Payables (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Payables of $2.6 million for Q4 2025, down 52.58% year-over-year from $5.5 million in Q4 2024, and down 17.64% quarter-over-quarter from $3.2 million in Q3 2025.
Editas Medicine (EDIT) Payables (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Payables for 11 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 52.58% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (down 52.58% YoY), while the FY2025 annual figure was $2.6 million, down 52.58% from the prior year.
- Payables declined to $2.6 million in Q4 2025 per EDIT's latest filing, from $3.2 million in the prior quarter.
- Across five years, Payables topped out at $13.8 million in Q2 2024 and bottomed at $2.6 million in Q4 2025.
- Historically, Payables has averaged $7.1 million across 5 years, with a median of $6.8 million in 2022.
- Annual changes were most pronounced in 2022 — Payables surged 100.94% — and 2025, when it sank 74.68%.
- Editas Medicine's Payables stood at $5.0 million in 2021, then soared by 88.34% to $9.5 million in 2022, then slipped by 13.06% to $8.3 million in 2023, then slumped by 33.57% to $5.5 million in 2024, then plunged by 52.58% to $2.6 million in 2025.
- Business Quant data shows EDIT's Payables at $2.6 million in Q4 2025, $3.2 million in Q3 2025, and $6.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 12.49 Mn |
| Jun 30, 2024 | 13.77 Mn |
| Mar 31, 2024 | 7.97 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 10.41 Mn |
| Jun 30, 2023 | 8.07 Mn |
| Mar 31, 2023 | 9.05 Mn |
| Dec 31, 2022 | 9.51 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 6.17 Mn |
| Mar 31, 2022 | 4.69 Mn |
| Dec 31, 2021 | 5.05 Mn |
| Sep 30, 2021 | 3.40 Mn |
| Jun 30, 2021 | 4.42 Mn |
| Mar 31, 2021 | 8.91 Mn |